-transparent.png){kind=logo}
In order to examine the in vivo activity of BMY-28100, serial quantitative nasal cultures were taken from 52 nasal carriers of Staphylococcus aureus following administration of the antimicrobial. Nasal carriage rates and mean log titers decreased significantly during (days 2-4 and 5-8) and following (days 1-2 and 6-7) treatment. No change in antibiotic sensitivities was noted in follow-up isolates, and the MIC90 remained at 2mcg/ml. BMY-28100 demonstrated good in vivo activity against Staphylococcus aureus.
Related Publications
R L Atmar, and
M L Allen, and
J Freiman, and
C Kiefe, and
S Ehrman, and
S B Greenberg
February 1987,
Antimicrobial agents and chemotherapy,
R L Atmar, and
M L Allen, and
J Freiman, and
C Kiefe, and
S Ehrman, and
S B Greenberg
April 1987,
Antimicrobial agents and chemotherapy,
R L Atmar, and
M L Allen, and
J Freiman, and
C Kiefe, and
S Ehrman, and
S B Greenberg
January 1988,
Chemotherapy,
R L Atmar, and
M L Allen, and
J Freiman, and
C Kiefe, and
S Ehrman, and
S B Greenberg
March 1987,
Antimicrobial agents and chemotherapy,
R L Atmar, and
M L Allen, and
J Freiman, and
C Kiefe, and
S Ehrman, and
S B Greenberg
February 1987,
European journal of clinical microbiology,
R L Atmar, and
M L Allen, and
J Freiman, and
C Kiefe, and
S Ehrman, and
S B Greenberg
June 1987,
European journal of clinical microbiology,
R L Atmar, and
M L Allen, and
J Freiman, and
C Kiefe, and
S Ehrman, and
S B Greenberg
February 1990,
Antimicrobial agents and chemotherapy,
R L Atmar, and
M L Allen, and
J Freiman, and
C Kiefe, and
S Ehrman, and
S B Greenberg
April 1987,
European journal of clinical microbiology,
R L Atmar, and
M L Allen, and
J Freiman, and
C Kiefe, and
S Ehrman, and
S B Greenberg
August 1987,
The Journal of antibiotics,
R L Atmar, and
M L Allen, and
J Freiman, and
C Kiefe, and
S Ehrman, and
S B Greenberg
March 1975,
Antimicrobial agents and chemotherapy,
